ClinicalTrials.gg
Sign In
Not yet recruitingNCT07002606Updated Jun 3, 2025

The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients in the Tertiary Healthcare Facility of Nepal. This Study Aims to Develop and Implement the Medication Errors Reporting System in Hospital Settings.

An observational study in Prescription With Medication Errors, sponsored by Kathmandu University School of Medical Sciences. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-06-03.

Sponsored by Kathmandu University School of Medical Sciences · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
62
Sex
All
01

Study summary

The goal of this observational study is to develop and implement Medication errors reporting system using the error reporting guidelines. The main question it aims to answer is:

"Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient safety?"

02

Conditions studied

  • Prescription With Medication Errors

Keywords

  • Medication errors
  • Mixed method study
  • tertiary healthcare facility
03

In context

Lead sponsor

Kathmandu University School of Medical Sciences is the lead sponsor of 26 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Healthcare professionals including Doctors, Nurses and Pharmacist who are working in Dhulikhel Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For the quantitative part, the inclusion criteria are patients of all age groups and prescriptions issued to inpatients.
  • For the qualitative part of the study, inclusion criteria are healthcare professionals aged more than 18 years working in Dhulikhel Hospital.

Exclusion criteria

Exclusion criteria:

  • The exclusion criteria will be incomplete and unclear prescriptions.
  • The healthcare persons who accepted the consent but couldn't complete the survey will be excluded from the study.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
62 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • Othermedication errors reporting guidelines

    the intervention is designed to reduce the medication errors and develop the culture of reporting the Medication errors in clinical settings.

06

What researchers measure

Primary outcomes

  1. reduction in Mediation error rate

    The newly developed Medication errors reporting guidelines will be implemented and will be used to evaluate the reduction in medication errors incident rates.

    Time frame: 6 months after the implementation of the Medication errors reporting guidelines

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07002606
Lead sponsor
Kathmandu University School of Medical Sciences
Responsible party
Rudip Thapa (Assistant Professor (Pharmacology), Kathmandu University School of Medical Sciences) — Principal investigator
First posted
Jun 3, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Jun 3, 2025

Study contacts

Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology
Contact
thaparudip@student.kusms.edu.np
+9779851218678
Dr. Sony Shakya Professor in Pharmacology, PhD
study director · Kathmandu University School of Medical Science

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Kathmandu University School of Medical Sciences

Start the discussion